Núria Climent

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Natural Killer Cells

Endoplasmic Reticulum Stress

Chronic Myeloid Leukemia

Top Venues

Development (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Rodríguez-Agustín, Víctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez-Palomino, José Alcamí, Núria Climent
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. Pharmaceutics 15 (3) (2023)
Andrea Rodríguez-Agustín, Víctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez-Palomino, José Alcamí, Núria Climent
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. Pharmaceutics 15 (3) (2023)
Andrea Rodríguez-Agustín, Víctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez-Palomino, José Alcamí, Núria Climent
Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. Pharmaceutics 15 (3) (2023)
Elena Melendez, Dafni Chondronasiou, Lluc Mosteiro, Jaime Martínez de Villarreal, Marcos Fernández-Alfara, Cian J Lynch, Dirk Grimm, Francisco X Real, José Alcamí, Núria Climent, Federico Pietrocola, Manuel Serrano
Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development (Cambridge, England) 149 (8) (2022)